Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study
Abstract Background OnabotulinumtoxinA (BOTOX®, Allergan plc, Dublin, Ireland) is approved for the preventive treatment of headaches in adult patients with chronic migraine (CM) in Australia by the country’s reimbursement mechanism for medicines, the Pharmaceutical Benefits Scheme (PBS). To our know...
Zapisane w:
| Główni autorzy: | , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2019-07-01
|
| Seria: | The Journal of Headache and Pain |
| Hasła przedmiotowe: | |
| Dostęp online: | http://link.springer.com/article/10.1186/s10194-019-1030-z |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|